Longeveron (LGVN) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

LGVN Stock Forecast


Longeveron stock forecast is as follows: an average price target of $10.00 (represents a 362.96% upside from LGVN’s last price of $2.16) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

LGVN Price Target


The average price target for Longeveron (LGVN) is $10.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $10.00 to $10.00. This represents a potential 362.96% upside from LGVN's last price of $2.16.

LGVN Analyst Ratings


Buy

According to 2 Wall Street analysts, Longeveron's rating consensus is 'Buy'. The analyst rating breakdown for LGVN stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Longeveron Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 29, 2024Raghuram SelvarajuH.C. Wainwright$10.00$3.44190.70%362.96%
Row per page
Go to

The latest Longeveron stock forecast, released on Jul 29, 2024 by Raghuram Selvaraju from H.C. Wainwright, set a price target of $10.00, which represents a 190.70% increase from the stock price at the time of the forecast ($3.44), and a 362.96% increase from LGVN last price ($2.16).

Longeveron Price Target by Period


1M3M12M
# Anlaysts--1
Avg Price Target--$10.00
Last Closing Price$2.16$2.16$2.16
Upside/Downside-100.00%-100.00%362.96%

In the current month, the average price target of Longeveron stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Longeveron's last price of $2.16. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Sep 04, 2024H.C. WainwrightBuyBuyHold
Aug 27, 2024Maxim GroupBuyBuyHold
Jul 29, 2024H.C. WainwrightBuyBuyHold
Row per page
Go to

Longeveron's last stock rating was published by H.C. Wainwright on Sep 04, 2024. The company gave LGVN a "Buy" rating, the same as its previous rate.

Longeveron Financial Forecast


Longeveron Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
Revenue-------------$150.00K$217.00K$279.00K$121.00K$265.00K$466.00K$370.00K$209.00K
Avg Forecast$1.23M$1.18M$1.09M$1.05M$609.50K$594.50K$564.00K$549.00K$408.00K$395.50K$500.00K$60.00K$210.00K$400.00K$400.00K$300.00K$400.00K$200.00K$200.00K$250.00K$265.00K
High Forecast$1.23M$1.18M$1.09M$1.05M$609.50K$594.50K$564.00K$549.00K$408.00K$430.40K$500.00K$60.00K$290.00K$400.00K$400.00K$300.00K$400.00K$200.00K$200.00K$250.00K$265.00K
Low Forecast$1.23M$1.18M$1.09M$1.05M$609.50K$594.50K$564.00K$549.00K$408.00K$348.97K$500.00K$60.00K$130.00K$400.00K$400.00K$300.00K$400.00K$200.00K$200.00K$250.00K$265.00K
# Analysts111111111211211111111
Surprise %-------------0.38%0.54%0.93%0.30%1.32%2.33%1.48%0.79%

Longeveron's average Quarter revenue forecast for Dec 23 based on 2 analysts is $210.00K, with a low forecast of $130.00K, and a high forecast of $290.00K. LGVN's average Quarter revenue forecast represents a 40.00% increase compared to the company's last Quarter revenue of $150.00K (Sep 23).

Longeveron EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts111111111211211111111
EBITDA-------------$-5.16M$-5.71M$-4.72M$-4.56M$-5.00M$-4.00M$-3.21M$-8.46M
Avg Forecast$-960.77K$-925.59K$-854.45K$-818.49K$-476.48K$-464.75K$-440.91K$-429.18K$-318.95K$-309.18K$-390.88K$-46.91K$-164.17K$-312.70K$-312.70K$-234.53K$-312.70K$-156.35K$-156.35K$-4.08M$-207.16K
High Forecast$-960.77K$-925.59K$-854.45K$-818.49K$-476.48K$-464.75K$-440.91K$-429.18K$-318.95K$-272.81K$-390.88K$-46.91K$-101.63K$-312.70K$-312.70K$-234.53K$-312.70K$-156.35K$-156.35K$-3.26M$-207.16K
Low Forecast$-960.77K$-925.59K$-854.45K$-818.49K$-476.48K$-464.75K$-440.91K$-429.18K$-318.95K$-336.46K$-390.88K$-46.91K$-226.71K$-312.70K$-312.70K$-234.53K$-312.70K$-156.35K$-156.35K$-4.89M$-207.16K
Surprise %-------------16.50%18.27%20.11%14.57%32.01%25.56%0.79%40.85%

undefined analysts predict LGVN's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Longeveron's previous annual EBITDA (undefined) of $NaN.

Longeveron Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts111111111211211111111
Net Income-------------$-5.90M$-5.63M$-4.58M$-3.77M$-5.30M$-7.03M$-3.63M$-8.92M
Avg Forecast----$-1.82M$-1.89M$-2.34M$-2.47M$-2.31M$-2.54M$-7.29M$-13.05M$-13.89M$-14.65M$-16.06M$-13.89M$-13.02M$-14.32M$-14.76M$-4.31M$-16.27M
High Forecast----$-1.82M$-1.89M$-2.34M$-2.47M$-2.31M$-2.44M$-7.29M$-13.05M$-12.57M$-14.65M$-16.06M$-13.89M$-13.02M$-14.32M$-14.76M$-3.45M$-16.27M
Low Forecast----$-1.82M$-1.89M$-2.34M$-2.47M$-2.31M$-2.63M$-7.29M$-13.05M$-15.21M$-14.65M$-16.06M$-13.89M$-13.02M$-14.32M$-14.76M$-5.17M$-16.27M
Surprise %-------------0.40%0.35%0.33%0.29%0.37%0.48%0.84%0.55%

Longeveron's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. LGVN's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Longeveron SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts111111111211211111111
SG&A-------------$3.37M$3.52M$2.01M$1.92M$2.32M$2.66M$2.27M$5.39M
Avg Forecast$8.39M$8.08M$7.46M$7.15M$4.16M$4.06M$3.85M$3.75M$2.78M$2.70M$3.41M$409.46K$1.43M$2.73M$2.73M$2.05M$2.73M$1.36M$1.36M$1.71M$1.81M
High Forecast$8.39M$8.08M$7.46M$7.15M$4.16M$4.06M$3.85M$3.75M$2.78M$2.94M$3.41M$409.46K$1.98M$2.73M$2.73M$2.05M$2.73M$1.36M$1.36M$1.71M$1.81M
Low Forecast$8.39M$8.08M$7.46M$7.15M$4.16M$4.06M$3.85M$3.75M$2.78M$2.38M$3.41M$409.46K$887.16K$2.73M$2.73M$2.05M$2.73M$1.36M$1.36M$1.71M$1.81M
Surprise %-------------1.24%1.29%0.98%0.70%1.70%1.95%1.33%2.98%

Longeveron's average Quarter SG&A projection for Dec 23 is $1.43M, based on 2 Wall Street analysts, with a range of $887.16K to $1.98M. The forecast indicates a -57.50% fall compared to LGVN last annual SG&A of $3.37M (Sep 23).

Longeveron EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21
# Analysts111111111211211111111
EPS-------------$-0.28$-0.27$-0.22$-0.18$-0.25$-0.34$-0.17$-0.45
Avg Forecast----$-0.28$-0.29$-0.36$-0.38$-0.35$-0.39$-1.12$-2.00$-2.13$-2.25$-2.47$-2.13$-2.00$-2.20$-2.27$-2.25$-2.50
High Forecast----$-0.28$-0.29$-0.36$-0.38$-0.35$-0.38$-1.12$-2.00$-1.93$-2.25$-2.47$-2.13$-2.00$-2.20$-2.27$-2.25$-2.50
Low Forecast----$-0.28$-0.29$-0.36$-0.38$-0.35$-0.40$-1.12$-2.00$-2.34$-2.25$-2.47$-2.13$-2.00$-2.20$-2.27$-2.25$-2.50
Surprise %-------------0.12%0.11%0.10%0.09%0.11%0.15%0.08%0.18%

According to undefined Wall Street analysts, Longeveron's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to LGVN previous annual EPS of $NaN (undefined).

Longeveron Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
KPRXKiora Pharmaceuticals$3.68$120.003160.87%Buy
BWVOnconetix$0.18$4.002122.22%Buy
KRONKronos Bio$0.95$7.63703.16%Buy
LGVNLongeveron$2.16$10.00362.96%Buy
LRMRLarimar Therapeutics$7.57$20.33168.56%Buy
KZRKezar Life Sciences$7.09$17.50146.83%Buy
ERASErasca$2.87$7.00143.90%Buy
CCCCC4 Therapeutics$6.45$13.50109.30%Buy
KROSKeros Therapeutics$59.95$102.0070.14%Buy
BOLTBolt Biotherapeutics$0.67$1.0049.25%Hold
EWTXEdgewise Therapeutics$34.48$45.0030.51%Buy

LGVN Forecast FAQ


Yes, according to 2 Wall Street analysts, Longeveron (LGVN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of LGVN's total ratings.

Longeveron (LGVN) average price target is $10 with a range of $10 to $10, implying a 362.96% from its last price of $2.16. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for LGVN stock, the company can go up by 362.96% (from the last price of $2.16 to the average price target of $10), up by 362.96% based on the highest stock price target, and up by 362.96% based on the lowest stock price target.

LGVN's average twelve months analyst stock price target of $10 supports the claim that Longeveron can reach $3 in the near future.

Longeveron's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $2.32M (high $2.32M, low $2.32M), average EBITDA is $-1.811M (high $-1.811M, low $-1.811M), average net income is $-8.528M (high $-8.528M, low $-8.528M), average SG&A $15.81M (high $15.81M, low $15.81M), and average EPS is $-1.31 (high $-1.31, low $-1.31). LGVN's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $4.55M (high $4.55M, low $4.55M), average EBITDA is $-3.559M (high $-3.559M, low $-3.559M), average net income is $0 (high $0, low $0), average SG&A $31.07M (high $31.07M, low $31.07M), and average EPS is $0 (high $0, low $0).

Based on Longeveron's last annual report (Dec 2023), the company's revenue was $709K, which missed the average analysts forecast of $1.31M by -45.88%. Apple's EBITDA was $-21.029M, beating the average prediction of $-1.024M by 1953.43%. The company's net income was $-22.211M, missing the average estimation of $-58.48M by -62.02%. Apple's SG&A was $12.18M, beating the average forecast of $8.94M by 36.29%. Lastly, the company's EPS was $-0.001, missing the average prediction of $-8.983 by -99.99%. In terms of the last quarterly report (Sep 2023), Longeveron's revenue was $150K, missing the average analysts' forecast of $400K by -62.50%. The company's EBITDA was $-5.161M, beating the average prediction of $-313K by 1550.46%. Longeveron's net income was $-5.904M, missing the average estimation of $-14.647M by -59.69%. The company's SG&A was $3.37M, beating the average forecast of $2.73M by 23.53%. Lastly, the company's EPS was $-0.28, missing the average prediction of $-2.25 by -87.56%